Recognition of impairment losses on investment securities
First written in FY2019. 2 of 8 entries say "Dropped", first in FY2022-Q3. Latest entry: FY2026.
The whole theme swung hardest in 2026: 35 of 80 companies on the "Worse" side.
52 other companies' latest entry also says "Other".
- FY2026Re-recognition of valuation losses on investment securitiesAnnual report
「During the fiscal year under review, the Company recorded an impairment loss of ¥4 million on securities, consisting of a ¥4 million loss on shares classified as other securities.」
Although no impairment loss was recorded in the previous fiscal year, the Company again recorded an impairment loss on investment securities of ¥4 million in the current fiscal year. - FY2025DroppedAnnual report
「Not applicable.」
No impairment loss was recorded on investment securities in FY2025. Although a loss on the sale of investment securities of ¥2 million was recorded, no impairment-loss recognition was reported for the fiscal year. - FY2023Re-recognition of valuation losses on investment securitiesAnnual report
「During the fiscal year under review, the Company recorded an impairment loss of ¥27 million on securities.」
The Company recorded an impairment loss of ¥27 million on investment securities in the fiscal year ended June 2023, whereas no such loss was recorded in the same period of the previous year. - FY2022-Q3DroppedAnnual report
「Impairment loss on investment securities ¥5.282 million −」
While an impairment loss on investment securities of ¥5.282 million was recorded in the same period of the previous year, no such loss was recorded during the 9-month period of the fiscal year under review. - FY2021-Q1Recognition of a quarterly impairment loss on investment securitiesAnnual report
「Impairment loss on investment securities − ¥5.282 million」
The Company recorded an impairment loss on investment securities of ¥5.282 million during the 3-month period of the fiscal year under review. - FY2020Recognition of a full-year impairment loss on investment securitiesAnnual report
「During the fiscal year under review, the Company recorded an impairment loss of ¥40.830 million on securities.」
The Company recorded an impairment loss of ¥40.830 million on investment securities during the fiscal year under review. - FY2020-Q3Recognition of a quarterly impairment loss on investment securitiesAnnual report
「Impairment loss on investment securities − ¥40.830 million」
The Company recorded an impairment loss on investment securities of ¥40.830 million during the 9-month period of the fiscal year under review. - FY2019First statedAnnual report
「During the fiscal year under review, the Company recorded an impairment loss of ¥153.386 million on securities.」
It was disclosed for the first time that the Company recorded an impairment loss of ¥153.386 million on investment securities as an extraordinary loss.